Demographics and comorbidities | Less than or 16 Sessions (n = 378) | 16 + Sessions (n = 123) | P-value |
---|---|---|---|
Age | 65.07 ± 10.02 | 66.31 ± 10.15 | 0.239 |
Sex | 0.038 | ||
Female | 191 (50.5) | 76 (61.8) | |
Male | 187 (49.5) | 47 (38.2) | |
White race | 309 (81.7) | 90 (73.2) | 0.055 |
BMI | 29.18 ± 5.31 | 29.66 ± 5.62 | 0.410 |
ASA 3 + | 126 (33.3) | 41 (33.3) | 1 |
OA | 366 (96.8) | 116 (94.3) | 0.274 |
Fracture | 5 (1.3) | 5 (4.1) | 0.071* |
AVN | 7 (1.9) | 2 (1.6) | 1* |
Obesity | 153 (40.5) | 57 (46.3) | 0.298 |
Diabetes | |||
Type 1 diabetes | 1 (0.3) | 0 (0) | 1* |
Type 2 diabetes | 46 (12.2) | 15 (12.2) | 1 |
Type 1 or 2 diabetes | 47 (12.4) | 15 (12.2) | 1 |
Sleep apnea | 47 (12.4) | 25 (20.3) | 0.043 |
COPD | 14 (3.7) | 6 (4.9) | 0.597 |
Liver disease | 7 (1.9) | 3 (2.4) | 0.713* |
Asthma | 33 (8.7) | 13 (10.6) | 0.665 |
AFIB | 23 (6.1) | 7 (5.7) | 1 |
CHF | 2 (0.6) | 1 (0.8) | 0.571* |
CAD | 38 (10.1) | 10 (8.1) | 0.651 |
ESRD CKD | 23 (6.1) | 6 (4.9) | 0.783 |
GERD | 109 (28.8) | 35 (28.5) | 1 |
Anxiety/depression | 78 (20.6) | 28 (22.8) | 0.708 |
HTN | 192 (50.8) | 68 (55.3) | 0.446 |
PVD | 0 (0) | 0 (0) | 1 |
Neoplasm | 7 (1.9) | 4 (3.3) | 0.476* |
Anemia | 8 (2.1) | 4 (3.3) | 0.500* |
HCC score | 0.49 ± 0.29 | 0.48 ± 0.21 | 1 |